One Ascent Financial Services LLC Regeneron Pharmaceuticals, Inc. Transaction History

One Ascent Financial Services LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	SELL	$700.03 - $830.35 $46,201 - $54,803	-66 Reduced 13.15%	436 $313,000
Q1 2023 Apr 17, 2023	BUY	$680.49 - $826.97 $51,717 - $62,849	76 Added 17.84%	502 $412,000
Q4 2022 Jan 12, 2023	BUY	$705.89 - $766.39 $300,709 - $326,482	426 New	426 $307,000
Q1 2022 May 12, 2022	SELL	$595.12 - $698.43 $315,413 - $370,167	-530 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$543.48 - $670.97 $288,044 - $355,614	530 New	530 $335,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of One Ascent Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on One Ascent Financial Services LLC with notifications on news.